ABSTRACT SPINAL CORD STIMULATION (SCS) has been increasingly used in the treatment of ischemia caused by obliterative diseases in the extremities and in the cardiac circulation. The most promising effects have been obtained when physicians suspect that a major vasospastic component underlies the ischemic symptoms (e.g., as in Raynaud's disease).
provocation of a second spasm was also greater in the SCS-treated group than in the control animals (50 and 14%, respectively; P < 0.05). Pilot studies showed that this protective effect was specific to SCS given before spasm induction, an observation corroborated by clinical experiences. Different hypothetical mechanisms based on these observations are discussed. Presently, available data favor a depression of sympathetically maintained vasoconstriction by SCS as an important factor, but some observations also point to the importance of a local release of vasoactive substances (e.g., the calcitonin gene-related peptide). The animal model used in the present study may supply a convenient system for future studies of the mechanisms behind the SCSenhanced resolution of vasospasm after different types of provocations.
Electrical spinal cord stimulation (SCS) is currently used in many centers to treat ischemic pain and ischemia in peripheral vascular disease. The most promising results in peripheral ischemia have been obtained when a vasospastic component is dominant (6, 19, 24) . SCS has also proved efficient in reducing pain in patients with cardiac arteriosclerosis, as well as in patients with angina who have angiographically normal vessels (Syndrome X) (1) . Furthermore, studies on animal models have demonstrated that high cervical SCS may reduce the vasospasm and restore the cerebral blood flow in experimental subarachnoidal hemorrhage (21, 26) . The knowledge concerning the mechanisms behind these beneficial effects has been fragmentary, but recent experimental studies indicate that suppression of sympathetic activity (14) (15) (16) 25) and the release of vasoactive substances (3, 20) may be important for the effect.
The causes of vasospasm are multiple (22) ; however, besides the endogenous factors, physical stress (especially stretching) to the vessels, both in plastic microsurgery and vascular neurosurgery, seems to be an important provoking agent. Experiments on isolated vessels in rats, with and without previous SCS, point to local changes in the vascular walls as a possible basis for the vasodilatory effects of stimulation (5).
Many animal studies aimed at exploring the mechanisms behind the microcirculatory changes induced by SCS have been performed on normal animals without ischemia (13) or on models of subarachnoid hemorrhage. However, in the studies of the responsiveness of local ischemia to various chemicals and to transcutaneous electric nerve stimulation (TENS), animal models with ischemic flaps have been used (10) . Furthermore, trials with TENS on patients who had undergone microsurgical procedures involving free neurovascular flaps with a risk of ischemia demonstrated that the microcirculation in the flaps remained significantly better with electrical stimulation than without (12, 18) .
In the present study, we applied SCS via implanted electrodes in a rat model of local vasospasm induced by the mechanical stimulation of the vessel supplying an island flap in the groin. This island flap model was described earlier by Gheradini et al. (4) . Pilot studies on single animals indicated that SCS was much more effective if applied before the spasm induction rather than after flap ischemia was evident. Therefore, we decided to test whether preemptive SCS would prevent or decrease both the vasospasm and the subsequent flap ischemia evoked by the physical manipulation of the feeding vessel.
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MATERIALS AND METHODS
Back to Top
Animals
Thirteen male Sprague-Dawley rats (body weight, 250-300 g) were housed in standard conditions (at a temperature of 20-22°C, in a light-cycled environment). They had free access to food and water. The procedures of this study were examined and approved by the Regional Ethical Committee for Animal Research.
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Surgery
The experimental protocol consisted of two surgical procedures, with a rest period of 3 to 5 days between the operations. For the first session (the implantation of the electrode system), surgical anesthesia was induced by 3% halothane in a mixture of 50% oxygen and 50% air delivered by an open-circuit nose mask system at 1.5 1/min. Body temperature was maintained at 37.5 ± 0.5°C by an automatic heating device (CMA/150, CMA Microdialysis AB, Stockholm, Sweden).
After a laminectomy was performed at T12, a monopolar system for spinal cord stimulation was implanted. This system had an intraspinal cathode (silver; diameter, 2.0 mm) placed extradurally at vertebral level T11 and an anode (silver; diameter, 6.0 mm) in the subcutaneous tissue over the rib cage. The leads from both electrodes were tunneled subcutaneously to a microcontact sutured to the skin in the neck of the animal.
This SCS system has been described in detail elsewhere (17) . After 3 to 5 days of recovery, the rats were anesthetized by intraperitoneal injection of chloral hydrate (0.4 g/kg), and with the rat in the supine position, a groin neurovascular flap based on the epigastric vessels was raised (4) . The flap consisted of the skin and the underlying inguinal fat pad. After the vessels were trimmed by using a microscope, the flap was loosely resutured to its anatomic bed by two stitches. This preparation allowed direct observation of the superficial epigastric vessels.
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Recording of microcirculation showed that this maneuver induced spasm, diminishing the diameter of the vessel proper and causing a decrease of microcirculation in its feeding territory as monitored by the LDF system. Two groups of animals were submitted to two spasm periods. In one group (Group A, n = 6), SCS was applied 20 minutes before the first provocation; in the other group (Group B, n = 7) no stimulation was applied via the implanted electrodes, so Group B served as a control group. The experimental protocol is shown in Figure 1 . The stimulation parameters used for SCS were tailored to be similar to those used clinically. SCS was delivered with monophasic pulses (50 Hz; pulse width, 0.2 ms) with two-thirds of the intensity required for a motor response (tonic contraction of the abdominal muscles at the level of the flap), which was tested immediately after the induction of anesthesia (14, 17) . This intensity activates the large-diameter, lowthreshold fibers only and does not recruite the high-threshold, small-diameter fibers subserving nociception, although it is effective in inducing peripheral vasodilation in both the skin and the muscle tissue (13) (14) (15) (16) (17) . The stimulating current was generated by a Grass standard stimulator via a Grass constant current unit (Grass Instruments, Quincy, MA). The current intensity used for the subsequent SCS varied between 0.6 and 2.2 mA in different animals.
Blood pressure monitoring The statistical tests were performed on the raw data but, for simplicity, the data in the Results section indicate the percentage of animals in a group reaching a specified recovery criterion. The log-rank exact test was used to determine whether the time to reach 50 and 100% of prespasm microcirculation was significantly different between the groups. The same test was used for the comparison of times to reach the maximum flap microcirculation after spasm induction, but the Wilcoxon rank sum test was used to test group differences in the maximal microcirculatory flow reached after a spasm period. Finally, the [chi] 2 test was used to test whether the number of flaps not reaching 50 and 100% recovery was significantly different between the groups (23) . In all instances, P < 0.05 was considered to indicate a significant difference.
Back to Top The data in Table 1 show that the recovery of microcirculation in the group with preemptive SCS was more satisfactory than the recovery in the control group. In the experimental group, a response pattern emerged indicating that SCS, delivered before spasm induction, increased both the number of flaps with complete recovery and the maximal microcirculation after the spasm period (expressed as LDF flux, PU).
Also, the capacity for restoration of blood flow in the flaps in the control group was almost eliminated after the second spasm, whereas 50% of the flaps in the SCS group recovered after the second spasm. Figure 4 shows the percentage of animals in the two groups reaching the 100% (Fig.   4A ) and the 50% (Fig. 4B ) recovery criteria after different periods of time. Marked and statistically significant differences were found between the two groups (the log-rank exact test, P < 0.05). Full recovery of the prespasm circulation was reached within 60 minutes after the first provocation by all the animals receiving preemptive SCS, Figure 4 whereas only about 25% of the animals in the control group had attained full recovery after this period of time. A 50% recovery was reached rapidly by all the SCS-treated animals (in 11-12 min). At that same time, only about 35% of the control animals had attained 50% recovery.
Recording of systemic blood pressure
The recordings of the systemic blood pressure displayed no significant changes during SCS, but during spasm provocation, slight increases were often observed. There were no significant differences between the two groups in this respect (data not shown).
DISCUSSION
The results of this study indicate that SCS, applied with current parameters similar to those used in the clinic, may considerably increase the recovery of microcirculation in an ischemic skin flap after mechanically induced vasospasm. Taking into consideration the observations from some pilot experiments in which the SCS was applied in some animals only after the appearance of the deficient microcirculation, as monitored by LDF (Linderoth B, Gherardini G, Ren B, and Lundeberg T, unpublished observations), we think that the stimulation must be delivered before spasm induction to be maximally effective. When the SCS was withheld until the appearance of ischemia, the deficient microcirculation developed about the same as in control animals. This observation also agrees with clinical reports from patients treated by SCS for Raynaud's disease, in whom a much better effect from stimulation was obtained if the SCS was used before the provocation of ischemic pain (e.g., by walking in cold weather) than if the SCS was applied after the pain and the pallor had already appeared.
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Earlier flap studies with electrical stimulation Earlier studies on ischemic flaps, both in experimental animals (10) and in patients undergoing plastic surgery (12, 18) , have demonstrated that ischemia is decreased and flap survival is enhanced by TENS given postoperatively. In contrast to our findings, in the animal studies previously cited (10), TENS given before the flap was raised had little effect on flap survival. However, the TENS intensity used was comparatively high in those studies, so the mode of action may be different from that in our studies.
These authors found that their high-intensity TENS could be effective even if applied extrasegmentally to the ischemic area, whereas their low-intensity TENS had to be applied in the proper segment (i.e., at the base of the ischemic flap) to retain its beneficial effect (10).
Possible effector mechanisms
The possible mechanisms for the decreased ischemia and increased flap survival with afferent stimulation of coarse fibers include the release of vasoactive substances like Substance P, the vasoactive intestinal polypeptide, and the calcitonin gene-related peptide (CGRP) (7, 10) . Some observations support a role for the CGRP; this substance has a much higher vasodilatory potency than the others mentioned above, and it does not evoke fluid extravasation and edema. Furthermore, vasodilation induced by Substance P depends on an intact endothelium whereas some of the CGRP's capacity for vasodilation seems to persist even after the endothelium is severely damaged, a situation often encountered in peripheral vascular disease (7).
Both in animal experiments (11) and in clinical studies (8), treatment with the CGRP markedly increased the survival of circulatory compromised skin flaps. In the clinical study (8) , intravenous administration of the CGRP was even more effective than the treatment with TENS. Furthermore, a recent study with the flap model used in the present study demonstrated that the topical application of the CGRP onto the feeding artery resulted in a resolution of the vasospasm that was faster and more complete than that seen in the untreated animals (4) (Gheradini G, Lundeberg T, Gazelius B, Brodda-Jansen G, Samuelson U, submitted for publication). The time course for the recovery of the flap circulation after the CGRP application was even faster than that after SCS in the present study. Although it has been hypothesized that the effects of TENS on the microcirculation in these circumstances are caused by a release of the CGRP (18) , to the best of our knowledge, this has not been directly demonstrated yet.
Some researchers have proposed that the effect of SCS in ischemia is caused by a transient depression of sympathetically maintained peripheral vasoconstriction (13, 14) . Furthermore, the effects of subsequent SCS have been decreased by various measures to eliminate or decrease the sympathetic activity, such as sympathetic block with guanethidine, ganglionic block with hexamethonium, the use of more receptor-specific antagonists, or surgical sympathectomy (14) (15) (16) . In animal Table 1 Figure 4
